Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009

NCT00735410 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Influenza, Vaccine

Interventions

BIOLOGICAL: Seasonal Influenza Vaccine

Sponsor

Novartis Vaccines